Ultrasound Technology Utilizes Elastography and Acoustic Structure Quantification
|
By MedImaging International staff writers Posted on 11 Nov 2009 |
A new ultrasound system provides cutting-edge technology including elastrography and acoustic structure quantification, incorporated into a compact platform with diagnostic precision in a small, environmentally friendly unit.
The compact platform Aplio MX is a new member of Toshiba Medical Systems (Tokyo, Japan) ultrasound product line. "We have built a tremendous success with Aplio XG and its advanced clinical applications, such as differential tissue harmonics, MicroPure, or the recently introduced precision imaging, just to name a few.” Dr. F. Christoph Simm, senior manager of the ultrasound business unit explained, "Many of these applications, such as quantitative elastography and acoustic structure quantification, are based on Toshiba's raw data technology. We know that there is a big demand for a premium platform capable of supporting these technologies at a price point slightly below Aplio XG. With Aplio MX we target precisely this market segment and we will be able to migrate important clinical tools once they become important for clinical routine also in future. Toshiba's quantitative elastography is a good example for such a development. With expanding the Aplio family we believe we can expand our market opportunities in the premium segment considerably.”
Aplio MX shares its core imaging architecture as well as its transducers with Toshiba's flagship diagnostic ultrasound system Aplio XG. Focused on clinical efficiency, Aplio MX features a complete range of advanced imaging functions including differential tissue, harmonics, ApliPure+ and precision imaging to provide unprecedented image clarity to the user for better informed disease management decisions in the shortest possible time.
Dr. Keith Dewbury, consultant radiologist of Southampton General Hospital (UK), said, "After using the new Aplio precision imaging to say that we were impressed would be an understatement. The software produced a simply stunning performance, improving both the contrast and the spatial resolution across all applications.”
Aplio MX is Toshiba's first diagnostic ultrasound system that has been awarded the ECP mark for outstanding environment-friendly product design. Dr. Joerg Schlegel, global marketing manager of the Ultrasound Business Group commented, "Being successfully listed for 10 consecutive years in the Dow Jones Sustainability World Index [DJSI] and as a top scorer in the environment category, Toshiba is clearly recognized as a driving force in the entire industry. With the introduction of Aplio MX we reach another milestone in minimizing environmental impact of our products throughout their entire lifecycle. An impressive 50% reduction in main body volume, very low energy consumption and the consistent use of electronic documentation and option software licensing help save valuable resources in manufacturing, packaging, shipping, as well as during the daily use of the product.”
The system is extremely lightweight and easy to move. It incorporates a complete set of innovations designed for better ergonomics, operator comfort, and productivity. The unit's fully programmable user interface as well as its adjustable main panel and 19-inch monitor with fully articulating arm allow sonographers to configure their work environment optimally according to their clinical needs and personal preferences. The pioneering IASSIST Workflow Navigation feature simplifies complex examinations through user-definable protocols and macro-driven operation of the system.
The system's three-dimensional (3D)/4D imaging package including the newly introduced third-generation high frequency volume transducer PVT-675MV extends Aplio MX's diagnostic capabilities into the next dimension of imaging and intervention by providing accurate renderings and arbitrary volume cuts in real time or offline.
The modular and upgradable platform of Aplio MX makes it easy for users to gradually introduce advanced tools such as 3D/4D, microcalcification detection with MicroPure, elastography or contrast-enhanced ultrasound (CEUS) into their clinical practice. While new technologies will continue to be developed and initially released on Toshiba's flagship system Aplio XG, they can quickly and easily be migrated to Aplio MX as soon as there is a strong demand for use in clinical routine.
Toshiba Medical Systems Corp. is an independent group company of Toshiba Corporation. The company is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as computed tomography (CT) scanners, X-ray, ultrasound, Nuclear Medicine, magnetic resonance imaging (MRI) equipment, and information systems for medical institutions.
Related Links:
Toshiba Medical Systems
The compact platform Aplio MX is a new member of Toshiba Medical Systems (Tokyo, Japan) ultrasound product line. "We have built a tremendous success with Aplio XG and its advanced clinical applications, such as differential tissue harmonics, MicroPure, or the recently introduced precision imaging, just to name a few.” Dr. F. Christoph Simm, senior manager of the ultrasound business unit explained, "Many of these applications, such as quantitative elastography and acoustic structure quantification, are based on Toshiba's raw data technology. We know that there is a big demand for a premium platform capable of supporting these technologies at a price point slightly below Aplio XG. With Aplio MX we target precisely this market segment and we will be able to migrate important clinical tools once they become important for clinical routine also in future. Toshiba's quantitative elastography is a good example for such a development. With expanding the Aplio family we believe we can expand our market opportunities in the premium segment considerably.”
Aplio MX shares its core imaging architecture as well as its transducers with Toshiba's flagship diagnostic ultrasound system Aplio XG. Focused on clinical efficiency, Aplio MX features a complete range of advanced imaging functions including differential tissue, harmonics, ApliPure+ and precision imaging to provide unprecedented image clarity to the user for better informed disease management decisions in the shortest possible time.
Dr. Keith Dewbury, consultant radiologist of Southampton General Hospital (UK), said, "After using the new Aplio precision imaging to say that we were impressed would be an understatement. The software produced a simply stunning performance, improving both the contrast and the spatial resolution across all applications.”
Aplio MX is Toshiba's first diagnostic ultrasound system that has been awarded the ECP mark for outstanding environment-friendly product design. Dr. Joerg Schlegel, global marketing manager of the Ultrasound Business Group commented, "Being successfully listed for 10 consecutive years in the Dow Jones Sustainability World Index [DJSI] and as a top scorer in the environment category, Toshiba is clearly recognized as a driving force in the entire industry. With the introduction of Aplio MX we reach another milestone in minimizing environmental impact of our products throughout their entire lifecycle. An impressive 50% reduction in main body volume, very low energy consumption and the consistent use of electronic documentation and option software licensing help save valuable resources in manufacturing, packaging, shipping, as well as during the daily use of the product.”
The system is extremely lightweight and easy to move. It incorporates a complete set of innovations designed for better ergonomics, operator comfort, and productivity. The unit's fully programmable user interface as well as its adjustable main panel and 19-inch monitor with fully articulating arm allow sonographers to configure their work environment optimally according to their clinical needs and personal preferences. The pioneering IASSIST Workflow Navigation feature simplifies complex examinations through user-definable protocols and macro-driven operation of the system.
The system's three-dimensional (3D)/4D imaging package including the newly introduced third-generation high frequency volume transducer PVT-675MV extends Aplio MX's diagnostic capabilities into the next dimension of imaging and intervention by providing accurate renderings and arbitrary volume cuts in real time or offline.
The modular and upgradable platform of Aplio MX makes it easy for users to gradually introduce advanced tools such as 3D/4D, microcalcification detection with MicroPure, elastography or contrast-enhanced ultrasound (CEUS) into their clinical practice. While new technologies will continue to be developed and initially released on Toshiba's flagship system Aplio XG, they can quickly and easily be migrated to Aplio MX as soon as there is a strong demand for use in clinical routine.
Toshiba Medical Systems Corp. is an independent group company of Toshiba Corporation. The company is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as computed tomography (CT) scanners, X-ray, ultrasound, Nuclear Medicine, magnetic resonance imaging (MRI) equipment, and information systems for medical institutions.
Related Links:
Toshiba Medical Systems
Latest Ultrasound News
- AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
- Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Channels
Radiography
view channel
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more
AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreGeneral/Advanced Imaging
view channelNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more
Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
Obesity surgery improves weight and comorbidity profiles, yet clinicians lack tools to monitor organ-level metabolic recovery after the procedure. A clear view of systemic changes could refine follow-up... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







